Key clinical point: A single postdelivery dose of intravenous amoxicillin-clavulanic acid significantly reduced infections after operative delivery.
Major finding: The risk ratio for probable or confirmed infection was 0.58 for those receiving prophylactic postdelivery amoxicillin-clavulanic acid (95% CI, 0.49-0.69, P less than .001).
Study details: Multisite, randomized, blinded, placebo-controlled trial of 3,427 term deliveries.
Disclosures: The United Kingdom’s National Institute for Health Research sponsored the study. Dr. Knight reported no conflicts of interest.
Knight M. et al. Am J Obstet Gynecol 2019 Jan;220;1:S685. Abstract LB 3.
This Week's Must Reads
AHA Statement: Accurate Measurement of BP, Hypertension; ePub 2019 Mar 4; Muntner, et al
Coffee Consumption & Plasma Biomarkers, Am J Clin Nutr; ePub 2019 Mar 5; Hang, et al
Is Adding Aspirin to Warfarin Therapy Beneficial? , JAMA Intern Med; ePub 2019 Mar 4; Schaefer, et al
Must Reads in Women's Health
Sedentary Behaviors & CVD Risk in Older Women, Circulation; 2019 Feb 19; Bellettiere, et al
USPSTF: Interventions to Avert Perinatal Depression, JAMA; 2019 Feb 12; US Preventive Services Task Force